EX-10.18
from 10-K
116 pages
Asset Purchase Agreement by and Among Codiak Biosciences, Inc. and Lonza Rockland, Inc. November 1, 2021 Portions of This Exhibit, Indicated by the Mark “[***],” Were Omitted and Have Been Filed Separately With the Securities and Exchange Commission Pursuant to the Registrant’s Application Requesting Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as Amended
12/34/56